A Clinical Trial to Evaluate the Efficacy and Safety of HRS-9821 Inhalation Suspension in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

NCT07640451 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD

Interventions

DRUG: HRS-9821 Inhalation Suspension
DRUG: HRS-9821 Placebo Inhalation Suspension

Sponsor

Guangdong Hengrui Pharmaceutical Co., Ltd